Kolexia
Trepo Christian Gastro-entérologie
Trepo Christian
Gastro-entérologie
Hôpital La Croix-Rousse
Lyon, France
91 Activités
7 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hépatite Hépatite C Hépatite B Hépatite C chronique Hépatite chronique Cirrhose du foie Carcinome hépatocellulaire Hépatite B chronique Hépatite A

Collaborateurs

Voir plus
Zoulim Fabien
Zoulim Fabien
Hôpital La Croix-Rousse, Lyon, France
Pradat Pierre-Francois
Pradat Pierre-Francois
Hôpital Pitie Salpetriere, Paris, France
Maynard Muet Marianne
Maynard Muet Marianne
Hôpital La Croix-Rousse, Lyon, France
Bailly Francois
Bailly Francois
Hôpital La Croix-Rousse, Lyon, France

Industries

Voir plus
INSTITUT MERIEUX
10 collaboration(s)
Dernière en 2023
A+A
4 collaboration(s)
Dernière en 2022
WorldOne
1 collaboration(s)
Dernière en 2020
Janssen
1 collaboration(s)
Dernière en 2020

Dernières activités

Voir plus
The 2020 Nobel prize of Medicine for three hepatitis C discovery pioneers: a medical history milestone.
Clinics and research in hepatology and gastroenterology   10 avril 2021
Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal.
PLoS neglected tropical diseases   16 décembre 2020
Contrasting Timing of Virological Relapse After Discontinuation of Tenofovir or Entecavir in Hepatitis B e Antigen-Negative Patients.
The Journal of infectious diseases   17 septembre 2019
Perinatal hepatitis B virus transmission in Lao PDR: A prospective cohort study.
PloS one   24 avril 2019
Non-F HBV/HDV-3 coinfection is associated with severe liver disease in Western Brazilian Amazon.
Journal of medical virology   11 février 2019
Safety, Antiviral Activity and PK of MRD of BI 201335 in Chronic Hepatitis C Patients Both Treatment Naive and -Experienced: Safety, Antiviral Activity, and Pharmacokinetics of Multiple Rising Oral Doses of BI 201335 NA in Treatment-naïve Patients With Chronic Hepatitis C Infection for 14 Days Monotherapy Followed by Combination With Pegylated Interferon and Ribavirin for an Additional 14 Days (Double-blind, Placebo Controlled), and in Treatment-experienced Patients With Chronic Hepatitis C Infection for 28 Days as Combination Therapy With Pegylated Interferon and Ribavirin (Open-label)
Essai Clinique (Boehringer Ingelheim)   07 août 2018
Hepatitis C in Laos: A 7-Year Retrospective Study on 1765 Patients.
Virologica Sinica   13 juin 2018
Hepatitis B and hepatitis D virus infections in the Central African Republic, twenty-five years after a fulminant hepatitis outbreak, indicate continuing spread in asymptomatic young adults.
PLoS neglected tropical diseases   26 avril 2018
Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacy.
Clinics and research in hepatology and gastroenterology   16 mars 2018
Efficiency and Safety of an Early Dose Adjustment of Ribavirin in Patients Infected With Hepatitis C Underexposed to the Drug and Treated With Peginterferon Ribavirin.
Therapeutic drug monitoring   29 novembre 2017